Font Size: a A A
Keyword [tumor-specific]
Result: 81 - 100 | Page: 5 of 7
81. The Effect Of Xiaoyi's Direct Moxibustion "Heshu" On The TSGF And Livin Of HCC Rats
82. 1.The Study Of Diagnosis And Prognosis Factors In Lung Cancer 2.Study Of The Prognosis Factor NCAPD2 In Triple Negative Breast Cancer
83. Study On The Factors Of Safety And Efficacy Of Novel Antibody-drug Conjugates
84. The Design Of Anti-tumor Drugs Based On Miniaturized And Functionalized Antibodies
85. Capsaicin Induces Immunogenic Cell Death In Human Osteosarcoma Cells
86. Based On SEER-database To Study The Factors Affecting The Survival Of Patients With Colorectal Adenocarcinoma
87. Analysis Of The Complications Arising In Bone Tumor-specific Prosthesis Replacement
88. Experimrntal Study Of CIK Cells And Tumor-specific Adenovirus KGHV500 Mediate Anti-p21Ras Single-chain Antibody Therapy In Gliomas
89. Evaluating The Translocation Properties Of A New Penetrating Peptide And Enhancing Its Tumor-specific Intracellular Delivery
90. Herpes Virus Engineered By CRISPR/Cas9 And Cre/Lox Systems For The Diagnosis And Treatment Of Tumors
91. Identification And Analysis Of Tumor Specific Markers In Serum Of Ovarian Cancer Patients
92. Inactivation Of Haploidentical CTL Induced By Dendritic Cells Can Inhibit Lung Cancer By Infusion
93. CIK Cells And Tumor-specific Proliferating Adenovirus KGHV500 Jointly Mediate The Experimental Study Of Anti-p21ras Single-chain Antibody In The Treatment Of Lung Cancer
94. CIK Cells And Ad5/F35 Tumor-specific Proliferating Adenovirus Jointly Mediated The Anti-p21Ras Single-chain Antibody For The Treatment Of Colorectal Cancer
95. The development of a tumor specific gene therapy vector for the treatment and diagnosis of metastatic breast cancer
96. Tumor-specific human primary T cells engineered to overexpress IL-2, IL-7, IL-15, or IL-21 confer varying degrees of tumor rejection and xenogeneic graft-versus-host disease in an immunodeficient mouse model
97. Provision of antigen-specific CD4+ T cells prevents the tolerization of CD8+ tumor-specific T cells in a mouse model of prostate cancer
98. Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors
99. Generation of tumor-specific immunity using HER2/neu positive tumor derived chaperone-rich cell lysate (CRCL)
100. The fate and function of tumor-specific T cells during immune reconstitution
  <<First  <Prev  Next>  Last>>  Jump to